Document Detail

Modulation of Multidrug Efflux Pump Activity by New Hydantoin Derivatives on Colon Adenocarcinoma Cells without Inducing Apoptosis.
MedLine Citation:
PMID:  21965738     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Hydantoin derivatives are very promising candidates to improve the efficacy of anticancer chemotherapy. Previously, we demonstrated that eight hydantoin derivatives inhibited the P-glycoprotein (ABCB1) efflux pump of mouse T-lymphoma cells, as well as acting synergistically with the anticancer drug doxorubicin.
MATERIALS AND METHODS: The activity of the hydantoin derivatives were investigated in another MDR cancer model, namely Colo 205/S sensitive and Colo 320/R resistant colon carcinoma cells respectively, having normal or overexpressed ABCB1 systems.
RESULTS: Among the hydantoin derivatives evaluated, BS-1, MN-3 and JH-63 were the most effective ABCB1 transporter inhibitors at the concentration of 4 mg/l on the Colo 320/R cells, compared to the positive control, verapamil.
CONCLUSION: The derivatives did not induce apoptosis of Colo 320/R resistant colon carcinoma cells, indicating that these hydantoin compounds are potent efflux pump inhibitors (EPI) without affecting the signalling pathways that regulate apoptosis.
Gabriella Spengler; Jadwiga Handzlik; Imre Ocsovszki; Miguel Viveiros; Katarzyna Kiec-Kononowicz; Joseph Molnar; Leonard Amaral
Related Documents :
2451628 - Differentiation pathways of ectodermal epithelial cells in hydra.
21664138 - New microtubule polymerization inhibitors comprising a nitrooxymethylphenyl group.
1499928 - Proliferation assay of human gastric remnant by bromodeoxyuridine and flow cytometry.
18201978 - Functional association between the helicobacter pylori virulence factors vaca and caga.
12724938 - Ldl oxidation by androgen exposure using mrc-5 cell line as a model.
25426558 - Patient-derived glioblastoma stem cells are killed by cd133-specific car t cells but in...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  31     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  3285-8     Citation Subset:  IM    
Institute of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm tér 10, H-6720 Szeged, Hungary,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevention of Mouse Lung Tumors by Combinations of Chemopreventive Agents using Concurrent and Seque...
Next Document:  Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma.